Literature DB >> 7341281

Bioavailability of potassium from controlled-release tablets with and without water loading.

H Bechgaard, N W Shephard.   

Abstract

The relative availability of potassium from a controlled-release multiple-units tablet (Kalinorm) and a single-unit tablet (Slow-K) were compared in 13 volunteers on a low potassium diet (less than 30 mmol), by observing changes in urinary potassium excretion after administration of a single dose of 32 mmol potassium, either with or without water loading. Irrespective of procedure, the two products had the same extent of availability. The use of water loading, and special precautions about the level of dietary potassium and its composition when studying urinary potassium excretion, are discussed. It is suggested that water loading should be avoided when investigating the rate of potassium excretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7341281     DOI: 10.1007/bf00637515

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Letter: Gastric ulceration after "slow-K".

Authors:  F G McMahon; K Akdamar
Journal:  N Engl J Med       Date:  1976-09-23       Impact factor: 91.245

2.  Slow release potassium chloride treatment.

Authors:  A D Howie; R W Strachan
Journal:  Br Med J       Date:  1975-04-26

3.  Letter: Slow-k ulceration of oesophagus with aneurysmal left atrium.

Authors:  A J McCall
Journal:  Br Med J       Date:  1975-07-26

4.  Perforation of small bowel due to slow release potassium chloride (slow-K).

Authors:  M A Farquharson-Roberts; A E Giddings; A J Nunn
Journal:  Br Med J       Date:  1975-07-26

5.  A method for testing intestinal irritancy of sustained release potassium chloride preparations in animals [proceedings].

Authors:  B P Block; M B Thomas
Journal:  J Pharm Pharmacol       Date:  1978-12       Impact factor: 3.765

6.  Pharmacokinetics and effects on fecal blood loss of a controlled release potassium chloride tablet.

Authors:  R L Tannen; A Cordano
Journal:  J Pharmacol Exp Ther       Date:  1978-01       Impact factor: 4.030

7.  Letter: Mouth ulceration and slow-release potassium tablets.

Authors:  B R McAvoy
Journal:  Br Med J       Date:  1974-10-19

8.  Bioavailability of potassium from a slow-release tablet.

Authors:  D Ben-Ishay; K Engelman
Journal:  Clin Pharmacol Ther       Date:  1973 Mar-Apr       Impact factor: 6.875

9.  Oesophageal obstruction and ulceration caused by oral potassium therapy.

Authors:  J Pemberton
Journal:  Br Heart J       Date:  1970-03

10.  [Experimental study on the tolerance of different oral potassium preparations in rats (author's transl)].

Authors:  H Renker; E Schaub; M Bürgin; A Zanoletti; K Chovan; A Müller
Journal:  Arzneimittelforschung       Date:  1977
  10 in total
  3 in total

1.  Kinetics of potassium excretion following oral supplements: evidence of induced natriuresis.

Authors:  A Rakhit; S Melethil; J D Arnold; W E Wagner
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

2.  Correlation of phenylpropanolamine bioavailability with gastrointestinal transit by scintigraphic monitoring of 111In-labeled hydroxypropylmethylcellulose matrices.

Authors:  L C Feely; S S Davis
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

Review 3.  Potassium Intake, Bioavailability, Hypertension, and Glucose Control.

Authors:  Michael S Stone; Lisa Martyn; Connie M Weaver
Journal:  Nutrients       Date:  2016-07-22       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.